TG THERAPEUTICS, INC. Trading Securities, Unrealized Holding Loss
TG THERAPEUTICS, INC. (TGTX) reported Trading Securities, Unrealized Holding Loss of $3.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:TradingSecuritiesUnrealizedHoldingLoss · last filed 2019-11-12
- TG THERAPEUTICS, INC. trading securities, unrealized holding loss for the quarter ending 2019-09-30 was $3.00K, a 50.00% increase year-over-year.
- TG THERAPEUTICS, INC. trading securities, unrealized holding loss for the quarter ending 2019-06-30 was -$3.00K.
- TG THERAPEUTICS, INC. trading securities, unrealized holding loss for the quarter ending 2019-03-31 was $3.00K.
- TG THERAPEUTICS, INC. trading securities, unrealized holding loss for the quarter ending 2018-12-31 was -$9.00K.
- TG THERAPEUTICS, INC. trading securities, unrealized holding loss for fiscal 2017 was $35.00K.
| Period end | Trading Securities, Unrealized Holding Loss 3 month | Trading Securities, Unrealized Holding Loss 6 month | Trading Securities, Unrealized Holding Loss 9 month | Trading Securities, Unrealized Holding Loss 12 month |
|---|---|---|---|---|
| 2019-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $3.00K 10-Q · filed 2019-11-12 | -$6.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | -$9.00K derived: sum of 3 quarters · filed 2019-11-12 | -$7.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-03-31 | $3.00K 10-Q · filed 2019-05-10 | -$6.00K derived: sum of 2 quarters · filed 2019-11-12 | -$4.00K derived: sum of 3 quarters · filed 2019-11-12 | |
| 2018-12-31 | -$9.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2019-11-12 | -$7.00K derived: sum of 2 quarters · filed 2019-11-12 | $10.00K 10-Q · filed 2019-11-12 | |
| 2018-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $19.00K 10-Q · filed 2018-11-09 | ||
| 2018-06-30 | $17.00K 10-Q · filed 2018-08-09 | |||
| 2017-12-31 | $35.00K 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |